Berenberg Bank Analysts Give Fresenius SE & Co KGaA (FRA:FRE) a €70.95 Price Target

Berenberg Bank set a €70.95 ($82.50) price target on Fresenius SE & Co KGaA (FRA:FRE) in a research note issued to investors on Tuesday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

A number of other equities research analysts also recently commented on FRE. Independent Research set a €53.00 ($61.63) price objective on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Friday, May 3rd. Credit Suisse Group set a €50.00 ($58.14) price objective on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Thursday, July 18th. Deutsche Bank set a €65.00 ($75.58) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Wednesday, July 24th. Morgan Stanley set a €50.00 ($58.14) price objective on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Wednesday, May 22nd. Finally, Barclays set a €52.00 ($60.47) price objective on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Thursday, July 18th. Nine analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock presently has an average rating of Buy and an average price target of €58.60 ($68.14).

Fresenius SE & Co KGaA stock opened at €44.71 ($51.98) on Tuesday. Fresenius SE & Co KGaA has a 52-week low of €60.16 ($69.95) and a 52-week high of €80.00 ($93.02). The business’s 50 day simple moving average is €46.65.

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Featured Article: Moving Average (MA)

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.